Note 13 - Shareholders' Equity

12 Months Ended

Dec. 31, 2022

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

Repurchase of Common Stock 

A summary of our previously authorized share repurchase plans, both of which are expired by their terms, is as follows:

($ in thousands, except share and per share amounts)	2021		2020
Maximum authorized share repurchase amount (1)	$	7,500	$	7,500
Date of plan's authorization by the Board		March 2021		February 2020
Funding source		Working capital		Working capital
Number of shares repurchased under the plan (shares)		-		129,095
Amount paid for shares repurchased	$	-	$	2,938
Weighted average price paid per share	$	-	$	22.76
Remaining amount of shares authorized to be purchased under the plan (in dollars)	$	7,500	$	4,562

⁽¹⁾ Common shares can be purchased in the open market or privately negotiated transactions over the next twelve months following the date of plan authorization.

Our previous shareholder repurchase program terminated expired on March 4, 2022. There has not been an announcement for a new repurchase program since the expiration prior program expired in March 2022.

Preferred Shares

The Company has authorized 250,000 shares of voting preferred stock with no par value. No shares are issued or outstanding. Also, the Company has authorized 250,000 shares of non-voting preferred stock with no par value. Of these, 125,000 shares have been designated Series A non-voting convertible preferred stock with a stated value of $0.06 per share, of which no shares are issued or outstanding at December 31, 2022 and 2021, respectively.